ASARININ

ASARININ Basic information
Product Name:ASARININ
Synonyms:(-)-SESAMINE;(-)-ASARININ;ASARININ;EPI-SESAMIN;(-)-5,5'-[(1R,3aα,4S,6aα)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[1,3-benzodioxole];5,5'-[(1R,3aα,4S,6aα)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis(1,3-benzodioxole);L-Asarinin;5-[4-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-1-yl]-1,3-benzodioxole
CAS:133-04-0
MF:C20H18O6
MW:354.35
EINECS:
Product Categories:Lichen Products
Mol File:133-04-0.mol
ASARININ Structure
ASARININ Chemical Properties
Melting point 121°
alpha D20 -118.6°; D23 -122° (chloroform)
Boiling point 504.4±50.0 °C(Predicted)
density 1.385±0.06 g/cm3(Predicted)
storage temp. -20°C Freezer
solubility Chloroform (Slightly), DMSO (Slightly, Sonicated)
form Solid
color White to Off-White
Safety Information
MSDS Information
ASARININ Usage And Synthesis
DescriptionAsarinin is a lignan that has been found in A. sieboldii. It is an epimer of sesamin and a noncompetitive inhibitor of Δ5-desaturase (Ki = 0.28 mM). It is selective for Δ5-desaturase over Δ6- and Δ9-desaturase. Asarinin is cytotoxic to A2780 and SKOV3 ovarian cancer cells (IC50s = 38.45 and 60.87 μM, respectively) but not immortalized ovarian surface epithelial cells (IC50 = >200 μM). It induces apoptosis and activates caspase-3, -8, and -9 in A2780 and SKOV3 cells.
Usesl-Asarinin in combination with pellitorine is a potential larvicides for the control of insecticide-resistant mosquito populations. Possesses antimicrobial activity.
targetIL Receptor | IFN-γ | CXCR | TLR
ASARININ Preparation Products And Raw materials
(-)-ASARININ 97,(-)-ASARININ 97%,ASARININ(P) Astragaloside II Jujuboside B Paederosidic acid MOLLUGIN Ganoderenic acid D Epmedin B ENTERODIOL (R)-(+)-2-METHYL-1-PHENYL-1-PROPANOL 3-BENZO[1,3]DIOXOL-5-YL-PROPAN-1-OL ASARININ (1R)-1-(3-METHOXYPHENYL)ETHANOL Sesamin 2,3-dibenzylbutane-1,4-diol 4-(4-METHOXYPHENYL)-1-BUTANOL Masoprocol Vanillyl butyl ether AKOS 243-52

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.